CINACALCET TRIMA 60 MG

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

CINACALCET AS HYDROCHLORIDE

Disponible desde:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD

Código ATC:

H05BX01

formulario farmacéutico:

FILM COATED TABLETS

Composición:

CINACALCET AS HYDROCHLORIDE 60 MG

Vía de administración:

PER OS

tipo de receta:

Required

Fabricado por:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

Área terapéutica:

CINACALCET

indicaciones terapéuticas:

Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet -Trima may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with:• parathyroid carcinoma.• primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.

Fecha de autorización:

2020-08-31

Información para el usuario

PATIENT LEAFLET IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s
prescription only
CINACALCET-TRIMA
30 MG, 60 MG, 90 MG
FILM-COATED TABLETS
ACTIVE INGREDIENT:
Each tablet contains: 30 mg, 60 mg, 90 mg cinacalcet
(as hydrochloride).
For
information
about
inactive
ingredients
and
allergens in this medicine, please see section 6
‘Additional information’.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU
START USING THIS MEDICINE. This leaflet contains
concise information about this medicine. If you
have any further questions, consult your doctor or
pharmacist.
This medicine has been prescribed for you. Do not
pass it on to others. It may harm them, even if it
seems to you that their medical condition is similar
to yours.
THIS
MEDICINE
IS
NOT
INTENDED
FOR
CHILDREN
UNDER 18 YEARS OLD.
1. WHAT IS THIS MEDICINE INTENDED FOR?
This
medicine
is
used
to
treat
secondary
hyperparathyroidism
in
patients
with
serious
kidney disease who need dialysis to clear their
blood of waste products.
to reduce hypercalcemia (high levels of calcium
in the blood) in patients with parathyroid cancer.
to reduce high levels of calcium in the blood
(hypercalcemia)
in
patients
with
primary
hyperparathyroidism
when
removal
of
the
parathyroid gland is not possible.
THERAPEUTIC GROUP:
This medicine regulates the levels of calcium and
has anti-parathyroid activity. It is used to treat
diseases caused by impaired function of the organs
called parathyroid glands. . BEFORE USING THIS MEDICINE:
DO NOT USE THIS MEDICINE IF:
You
are
sensitive
(allergic)
to
the
active
ingredient cinacalcet or to any of the other
ingredients in this medicine (listed in section 6).
SPECIAL WARNINGS ABOUT USING THIS MEDICINE:
Consult a doctor, pharmacist, or nurse before you
take Cinacalcet-Trima.
BEFORE
YOU
START
TREATMENT
WITH
CINACALCET-
TRIMA, TELL YOUR DOCTOR IF:
you have or have ever had:
epileptic seizures (convulsions or spasms). The
risk of having these seizures is higher in patients
who have had seizu